Dose-Ranging Study of LQ036 Single-Domain Antibody Nebulization Solution in Poorly Controlled Asthma

Abroad (travel likely)RecruitingPHASE2

Conditions

Asthma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Contact: Study coordinator (Jieming Qu, Principal Investigator) · Jmqu0906@163.com · +86-21-64370045
Contact: Study coordinator (Wei Tang, Principal Investigator) · Tw10986@rjh.com.cn · +86-21-64370045

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma

Asthma

Abroad (travel likely)RecruitingPHASE2

Vancouver, Canada · Calgary, Canada

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

Allergic Asthma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Asthma

IsraelRecruitingPHASE2

Bakersfield, United States · Huntington Beach, United States

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Asthma

Abroad (travel likely)RecruitingPHASE3

Montgomery, United States · Phoenix, United States